{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:21:59Z","timestamp":1789683719289,"version":"4.0.1"},"reference-count":30,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Palliative Medicine Reports"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>We describe characteristics of patient and treatment recommendations from a spinal tumor board at one institution, including representation from palliative care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The impact of prospective multidisciplinary input for patients with spinal tumors is poorly understood despite their increasing complexity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively reviewed 622 cases sequentially discussed at a weekly spinal tumor board, and abstracted patient and treatment information from the medical record and meeting minutes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From April 2017 to February 2019, 622 cases representing 438 unique patients were discussed. The median age was 62 years (range 21\u201392). Most patients had spinal tumors originating from metastases (91.78%), including breast (14.3%), nonsmall cell lung cancer (13.4%), prostate (10.9%), and renal cell cancer (8.8%), and the remainder had primary central nervous system (4.3%) or benign tumors (3.9%). Sixty-five percent of patients were alive at last follow-up. Conventional external beam radiotherapy was the most common treatment recommendation (33.8%) followed by surgery (26.2%), stereotactic body radiation therapy (17.8%), imaging follow-up (16.6%), and vertebroplasty (15.9%). Palliative care was the primary treatment recommended for 4.5%, and no therapy recommended for 4.0%. Treatment recommendation involved two modalities for 29% of cases, and three in 1.3% of cases. In four cases, biopsy to confirm pathology changed management due to unexpected findings of osteomyelitis, hematopoiesis, or new diagnosis of plasmacytoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Multidisciplinary input is integral to the optimal care of spinal tumor patients. The high risk of death highlights the need to prioritize modalities that optimize quality of life in the context of a patient's individual prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/pmr.2020.0070","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:51:55Z","timestamp":1596721915000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Characteristics of Patients and Treatment Recommendations from a Multidisciplinary Spinal Tumor Program"],"prefix":"10.1177","volume":"1","author":[{"given":"Mai Anh","family":"Huynh","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Roldan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Nunes","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mohsin","family":"Fareed","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gorman","sequence":"additional","affiliation":[{"name":"Department of Adult Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Groff","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ferrone","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, and Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Spektor","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Balboni","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber\/Brigham and Women's Cancer Center, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1245\/s10434-012-2644-4","article-title":"Prognostic factor analysis in patients with metastatic spine disease depending on surgery and conservative treatment","volume":"20","author":"Lee BH","year":"2013","unstructured":"Lee BH, , Kim TH, , Chong HS, et al.: Prognostic factor analysis in patients with metastatic spine disease depending on surgery and conservative treatment: Review of 577 cases. Ann Surg Oncol, 2013; 20:40\u201346.","journal-title":"Review of 577 cases. Ann Surg Oncol"},{"key":"e_1_3_6_3_2","first-page":"11","article-title":"Contemporary spinal oncology treatment paradigms and outcomes for metastatic tumors to the spine","volume":"41","author":"Yao A","year":"2017","unstructured":"Yao A, , Sarkiss CA, , Ladner TR, , Jenkins ALIII: Contemporary spinal oncology treatment paradigms and outcomes for metastatic tumors to the spine: A systematic review of breast, prostate, renal, and lung metastases. J Clin Neurosci, 2017; 41:11\u201323.","journal-title":"A systematic review of breast, prostate, renal, and lung metastases. J Clin Neurosci"},{"key":"e_1_3_6_4_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0030-5898(05)70171-1","article-title":"Incidence, location, and diagnostic evaluation of metastatic bone disease","volume":"31","author":"Hage WD","year":"2000","unstructured":"Hage WD, , Aboulafia AJ, , Aboulafia DM: Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin N Am, 2000; 31:515\u2013528.","journal-title":"Orthop Clin N Am"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3922-0"},{"key":"e_1_3_6_6_2","doi-asserted-by":"crossref","unstructured":"Laufer I Rubin DG Lis E et al.: The NOMS framework: Approach to the treatment of spinal metastatic tumors. Oncologist. 2013; 18:744\u2013751.","DOI":"10.1634\/theoncologist.2012-0293"},{"key":"e_1_3_6_7_2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5312\/wjo.v3.i8.114","article-title":"Complications in the management of metastatic spinal disease.","volume":"3","author":"Dunning EC","year":"2012","unstructured":"Dunning EC, , Butler JS, , Morris S: Complications in the management of metastatic spinal disease. World J Orthop, 2012; 3:114\u2013121.","journal-title":"World J Orthop"},{"key":"e_1_3_6_8_2","doi-asserted-by":"crossref","unstructured":"Bishop AJ Tao R Rebueno NC et al.: Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence. Int J Radiat Oncol Biol Phys 2015;92:1016\u20131026.","DOI":"10.1016\/j.ijrobp.2015.03.037"},{"key":"e_1_3_6_9_2","doi-asserted-by":"crossref","unstructured":"Mehta N Zavitsanos PJ Moldovan K et al.: Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases. Adv Radiat Oncol 2018;3:245\u2013251.","DOI":"10.1016\/j.adro.2018.04.002"},{"key":"e_1_3_6_10_2","doi-asserted-by":"crossref","unstructured":"Laufer I Iorgulescu JB Chapman T et al.: Local disease control for spinal metastases following \u201cseparation surgery\u201d and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: Outcome analysis in 186 patients. J Neurosurg Spine 2013;18:207\u2013214.","DOI":"10.3171\/2012.11.SPINE12111"},{"key":"e_1_3_6_11_2","doi-asserted-by":"crossref","unstructured":"Ciftdemir M Kaya M Selcuk E Yalniz E: Tumors of the spine. World J Orthop. 2016; 7:109\u2013116.","DOI":"10.5312\/wjo.v7.i2.109"},{"key":"e_1_3_6_12_2","first-page":"928","article-title":"Vertebral compression fractures after stereotactic body radiation therap","volume":"24","author":"Jawad MS","year":"2016","unstructured":"Jawad MS, , Fahim DK, , Gerszten PC, et al.: Vertebral compression fractures after stereotactic body radiation therapy: A large, multi-institutional, multinational evaluation. J Neurosurg Spine, 2016; 24:928\u2013936.","journal-title":"A large, multi-institutional, multinational evaluation. J Neurosurg Spine"},{"key":"e_1_3_6_13_2","doi-asserted-by":"crossref","unstructured":"Prades J Remue E van Hoof E Borras JM : Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy 2015;119:464\u2013474.","DOI":"10.1016\/j.healthpol.2014.09.006"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12765"},{"key":"e_1_3_6_15_2","doi-asserted-by":"crossref","unstructured":"Ecker RD Endo T Wetjen NM Krauss WE: Diagnosis and treatment of vertebral column metastases. Mayo Clinic Proc 2005;80:1177\u20131186.","DOI":"10.4065\/80.9.1177"},{"key":"e_1_3_6_16_2","doi-asserted-by":"crossref","unstructured":"Bird JM Owen RG D'Sa S et al.: Guidelines for the diagnosis and management of multiple myeloma. 2011. Br J Haematol 2011;154:32\u201375.","DOI":"10.1111\/j.1365-2141.2011.08573.x"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.3.154"},{"key":"e_1_3_6_18_2","doi-asserted-by":"crossref","unstructured":"Ju DG Yurter A Gokaslan ZL Sciubba DM: Diagnosis and surgical management of breast cancer metastatic to the spine. World J Clin Oncol 2014;5:263\u2013271.","DOI":"10.5306\/wjco.v5.i3.263"},{"key":"e_1_3_6_19_2","doi-asserted-by":"crossref","unstructured":"Onufrey V Mohiuddin M: Radiation therapy in the treatment of me tastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 1985;11:2007\u20132009.","DOI":"10.1016\/0360-3016(85)90285-8"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","unstructured":"Wro\u0144ski M Maor MH Davis BJ et al.: External radiation of brain metastases from renal carcinoma: A retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 1997; 37:753\u2013759.","DOI":"10.1016\/S0360-3016(97)00006-0"},{"key":"e_1_3_6_21_2","doi-asserted-by":"crossref","unstructured":"Maranzano E Latini P: Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: Final results from a prospective trial. Int J Radiat Oncol Biol Phys 1995;32:959\u2013967.","DOI":"10.1016\/0360-3016(95)00572-G"},{"key":"e_1_3_6_22_2","doi-asserted-by":"crossref","unstructured":"Coppin C Kollmannsberger C Le L et al.: Targeted therapy for advanced renal cell cancer (RCC): A Cochrane systematic review of published randomised trials. BJU Int 2011;108:1556\u20131563.","DOI":"10.1111\/j.1464-410X.2011.10629.x"},{"key":"e_1_3_6_23_2","doi-asserted-by":"crossref","unstructured":"Flanigan R Campbell S Clark J Picken M: Metastatic renal cell carcinoma. Curr Treat Options Oncol 2003;4:385\u2013390.","DOI":"10.1007\/s11864-003-0039-2"},{"key":"e_1_3_6_24_2","first-page":"1221","article-title":"A novel classification system for spinal instability in neoplastic disease","volume":"35","author":"Fisher CG","unstructured":"Fisher CG, , DiPaola CP, , Ryken TC, et al.: A novel classification system for spinal instability in neoplastic disease:An evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine 2010;35:1221\u20131229.","journal-title":"An evidence-based approach and expert consensus from the Spine Oncology Study Group"},{"key":"e_1_3_6_25_2","first-page":"794","volume":"37","author":"Rosenberg AE","unstructured":"Rosenberg AE: Bone Sarcoma Pathology: Diagnostic Approach for Optimal Therapy. American Society of Clinical Oncology Educational Book American Society of Clinical Oncology Annual Meeting 2017;37:794\u2013798.","journal-title":"Bone Sarcoma Pathology: Diagnostic Approach for Optimal Therapy"},{"key":"e_1_3_6_26_2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12032-017-0966-6","article-title":"Progress and challenges in the treatment of small cell lung cancer","volume":"34","author":"Tartarone A","year":"2017","unstructured":"Tartarone A, , Giordano P, , Lerose R, et al.: Progress and challenges in the treatment of small cell lung cancer. Med Oncol, 2017; 34:110.","journal-title":"Med Oncol"},{"key":"e_1_3_6_27_2","first-page":"215","article-title":"Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer","volume":"2","author":"Ahmed KA","year":"2012","unstructured":"Ahmed KA, , Barney BM, , Davis BJ, et al.: Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol, 2012; 2:215.","journal-title":"Front Oncol"},{"key":"e_1_3_6_28_2","doi-asserted-by":"crossref","unstructured":"Myrehaug S Sahgal A Hayashi M et al.: Reirradiation spine stereotactic body radiation therapy for spinal metastases: Systematic review. J Neurosurg Spine 2017;27:428\u2013435.","DOI":"10.3171\/2017.2.SPINE16976"},{"key":"e_1_3_6_29_2","doi-asserted-by":"crossref","unstructured":"Palma DA Olson R Harrow S et al.: Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised phase 2 open-label trial. Lancet 2019;393:2051\u20132058.","DOI":"10.1016\/S0140-6736(18)32487-5"},{"key":"e_1_3_6_30_2","doi-asserted-by":"crossref","unstructured":"Bilsky MH Laufer I Fourney DR et al.: Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 2010;13:324\u2013328.","DOI":"10.3171\/2010.3.SPINE09459"},{"key":"e_1_3_6_31_2","doi-asserted-by":"crossref","unstructured":"Laufer I Zuckerman SL Bird JE et al.: Predicting neurologic recovery after surgery in patients with deficits secondary to MESCC: Systematic review. Spine (Phila Pa 1976) 2016;41 Suppl 20:S224\u2013S230.","DOI":"10.1097\/BRS.0000000000001827"}],"container-title":["Palliative Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/pmr.2020.0070","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pmr.2020.0070","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pmr.2020.0070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:55:20Z","timestamp":1777679720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/pmr.2020.0070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1089\/pmr.2020.0070"],"URL":"https:\/\/doi.org\/10.1089\/pmr.2020.0070","relation":{},"ISSN":["2689-2820","2689-2820"],"issn-type":[{"value":"2689-2820","type":"print"},{"value":"2689-2820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"article-number":"pmr.2020.0070"}}